Source Sought Notice - RepoCHEM SL Atropine

Notice ID:

BARDA-RepoCHEM-SL-Atropine-SSN

Department/Ind. Agency:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub-tier:

HEALTH AND HUMAN SERVICES, DEPARTMENT OF

Sub Command:

BARDA - ASPR / DAAPPO / BARDA DCMA

Office:

BARDA - ASPR / DAAPPO / BARDA DCMA

All Dates/Times are:

(utc-04:00) eastern standard time, new york, usa

Updated Published Date:

(utc-04:00) eastern standard time, new york, usa

Original Published Date:

2022-05-19 11:30:00

Original Response Date:

jul 29, 2022 04:00 pm edt

Inactive Policy:

manual

Original Inactive Date:

jul 30, 2022

Initiative:

• None***--***

Original Set Aside:

The purpose of this Sources Sought Notice (RepoChem - Sublingual Atropine) is to seek declarations of technical capabilities, data, and materials from qualified other than small business concerns as well as small business concerns relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. The NAICS for this requirement is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). The Office of the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use responses to this Sources Sought Notice (SSN) for planning a potential future challenge competition or other competition. BARDA seeks pertinent marketplace data on availabilities and capabilities for investing in the late-stage development of sublingual administration of 1% ophthalmic atropine as a contingency nerve agent medical countermeasure. BARDA seeks information on availability, capabilities, and other pertinent marketplace data to support late-stage activities required for Food and Drug Administration (FDA) label expansion of ophthalmic atropine for sublingual administration to treat organophosphate pesticide and nerve agent exposure. This information is intended to strengthen BARDA’s understanding of the current and future marketplace and enhance its ability to obtain quality services economically and efficiently, and to lawfully establish potential vendor source files and listings. BARDA will not award any contracts under this Notice.

O’NEILL HOUSE OFFICE BUILDING

WASHINGTON , DC 20515

USA

Primary Point of Contacts:

Richard Hall

Secondary Point of Contact:

Jonathan Gonzalez